Filing Details

Accession Number:
0001214659-22-015441
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-12-29 06:00:12
Reporting Period:
2022-12-27
Accepted Time:
2022-12-29 06:00:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1677077 Alzamend Neuro Inc. ALZN () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1212502 Iii C Milton Ault 11411 Southern Highlands Parkway
Suite 240
Las Vegas NV 89141
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-12-27 900 $0.59 11,046,901 No 4 P Indirect By Ault Lending, LLC
Common Stock Acquisiton 2022-12-28 3,100 $0.56 11,050,001 No 4 P Indirect By Ault Lending, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Ault Lending, LLC
No 4 P Indirect By Ault Lending, LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,500,000 Direct
Common Stock 365,000 Indirect By Ault Alpha LP
Common Stock 14,942,984 Indirect By Ault Life Sciences, Inc.
Common Stock 10,000,000 Indirect By Ault Life Sciences Fund, LLC
Footnotes
  1. Ault Lending, LLC ("Ault Lending"), is a wholly-owned subsidiary of BitNile Holdings, Inc. ("BH"). Mr. Ault, the Executive Chairman of BH, is deemed to have voting and investment power with respect to the securities held of record by Ault Lending.
  2. The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.5629. The range of purchase prices on the transaction date was $0.5594 to $0.5754 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.
  3. Milton C. Ault, III, is the Manager of Ault Alpha GP LLC ("Ault GP") and Ault Capital Management LLC ("AC Management"). Ault GP and AC Management are the general partner and investment manager to Ault Alpha LP, respectively. As such, Mr. Ault is deemed to beneficially own the shares held by Ault Alpha LP.
  4. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences, Inc.
  5. Mr. Ault has sole voting and investment power with respect to the securities held of record by Ault Life Sciences Fund, LLC.